Stoke Therapeutics Inc (STOK) is higher by 3.69% Wednesday In Premarket Trading

Stoke Therapeutics Inc (STOK) is higher by Wednesday morning, with the stock increasing 3.69% in pre-market trading to 10.67. STOK's short-term technical score of 84 indicates that the stock has traded more bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, Stoke Therapeutics Inc ranks higher than 90% of stocks. Stoke Therapeutics Inc has risen 73.23% over the past month, closing at $7.96 on February 28. During this period of time, the stock fell as low as $5.80 and as high as $8.58. STOK has an average analyst recommendation of Strong Buy. The company has an average price target of $19.86.

STOK has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on STOK!

See Full STOK Report

Stoke Therapeutics Inc has a Long-Term Technical rank of 99. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 1% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, STOK ranks better than 69% of stocks.

Important Dates for Investors in STOK:

-Stoke Therapeutics Inc is set to release earnings on 2024-05-02. Over the last 12 months, the company has reported EPS of $-2.10. -We do not have a set dividend date for Stoke Therapeutics Inc at this time. Click Here To Get The Full Report on Stoke Therapeutics Inc (STOK)